Coexistence of schwannomatosis and glioblastoma in two families.
Adult
Aged
Carcinogenesis
/ genetics
Female
Genetic Predisposition to Disease
Germ-Line Mutation
/ genetics
Glioblastoma
/ complications
Humans
Male
Neurilemmoma
/ complications
Neurofibromatoses
/ complications
Pedigree
SMARCB1 Protein
/ genetics
Skin Neoplasms
/ complications
Transcription Factors
/ genetics
Glioblastoma
LZTR1
Neurofibromatosis
SMARCB
Schwannomatosis
Journal
European journal of medical genetics
ISSN: 1878-0849
Titre abrégé: Eur J Med Genet
Pays: Netherlands
ID NLM: 101247089
Informations de publication
Date de publication:
Aug 2019
Aug 2019
Historique:
received:
29
10
2018
revised:
20
02
2019
accepted:
19
05
2019
pubmed:
28
5
2019
medline:
18
12
2019
entrez:
26
5
2019
Statut:
ppublish
Résumé
Schwannomatosis is a rare affection predisposing to multiple peripheral neurologic tumors development. Approximatively, one third of patients with schwannomatosis are carriers of a germline mutation in LZTR1 (Leucin Zipper Transcription Regulator 1). Tumorigenesis in schwannomatosis responds to a somatic 5-hit/3-step mechanism resulting in a loss of function (LOF) of LZTR1 and the contiguous genes of locus 22q11.2q12.2. Effectively, LZTR1 is mapped on 22q11.2 and centromeric to SMARCB1 also implicated in the determinism of schwannomatosis and NF2, responsible for neurofibromatosis type 2. On a somatic point of view, LZTR1 mutations are known to drive with a significant frequency glioblastoma (GB) development. We report here two families in which segregate both multiple schwannomas and GB. In the first family, the proband received a diagnosis with of schwannomatosis after a surgery for a lumbar schwannoma at age 43, molecularly confirmed by identification of a germline heterozygous mutation in LZTR1. Her father, having unremarkable medical history deceased from an apparently isolated GB at age 59. In the second family, LZTR1-related schwannomatosis was diagnosed in the index case at age 70 after multiple schwannomas surgeries. Her elder sister had no neurological medical history before occurrence of a lethal GB at age 78. Molecular analysis of GB sample from both affected relatives showed the presence of the familial mutation. These observations hypothesize a potential link between schwannomatosis and the GB development.
Identifiants
pubmed: 31128261
pii: S1769-7212(18)30808-5
doi: 10.1016/j.ejmg.2019.103680
pii:
doi:
Substances chimiques
LZTR1 protein, human
0
SMARCB1 Protein
0
Transcription Factors
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
103680Informations de copyright
Published by Elsevier Masson SAS.